SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David S. who wrote (3362)12/17/1997 4:00:00 PM
From: JOHN W.  Read Replies (1) of 6136
 
<<I too, share the joy in that Agouron received a gold star in San Diego. Is it in the form of a refrigerator magnet? Along other lines, Cell Genesis will soon release clinical results from their T-Cell gene therapy protocol. Any idea how that would change treatment when/if it became available?>>
It was an article regarding this threads company. Did you see any comments about it from me? So why attack it?

They already stated that it would if and when approved (2000?), it would be used in conjunction with current combination therapy. But, go ahead and make up crap to counter that.

Are you Biopoor? You both make up the most useless and annoying posts that are always negative regarding AGPH, foe entertainment purposes only since no one ever has a financial interest in this company's failure. You are a waste of my time and never provide an intelligent counter perspective.

How about a preview to Nov scrip data that will be available tommorrow? I suppose you will continually say month after month that it is strong, but will soon slow.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext